금융 뉴스 허브

Sector Update: Energy Stocks Mixed Late Afternoon

Energy stocks were mixed late Wednesday afternoon, with the NYSE Energy Sector Index rising 0.2% and

Stocks Hitch a Ride on the Bond Market's Rally

The stock market rode the bond market's coattails en route to its first gain in four sessions. The Nasdaq Composite gained 0.2%. News that the Treasury Department will at least double the size of bu ...

Why State Street SPDR Developed World ex-US is a Strong International ETF

Schwab outperformed on returns and volatility over five years, while State Street provides broader diversification with nearly 1,000 additional holdings.

US Equity Indexes Rise After Treasury Lifts Buyback Limit, Fed Minutes Show Most FOMC Participants Agreed to Hold Rates Steady at July Meeting

US equity indexes rose ahead of the close on Wednesday after the Treasury Department said it would i

Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally

The biopharmaceutical sector has struggled with a prolonged downturn in recent years but has been on an upswing of late.

EUFN vs KRE: European Banks vs. U.S. Regional Banks -- Which Financial Sector ETF Is the Better Buy?

KRE has experienced deeper drawdowns over the last five years, while EUFN -- despite higher fees -- delivered stronger returns over the same time period.

Evercore Revamps S&P 500 Price Target for 2026

The AI bull market may still be far from finished

Stocks Hold Onto Gains After Fed Minutes

The stock market held onto modest gains after minutes from the Federal Reserve’s July meeting highlighted a split among central bankers. The Nasdaq Composite was up 0.2%. There were three dissenters ...

Cytokinetics Gains 20.5% YTD: Buy, Sell or Hold the Stock?

Myqorzo's early launch momentum and global expansion could boost Cytokinetics, while pipeline progress may widen its growth opportunity.

Cybersecurity ETFs to Buy as Top Holdings Deliver Robust Q2 Results

Cybersecurity ETFs gain momentum as cyber leaders like FTNT post strong Q2 results, fueled by rising AI-driven threats and demand for security.

Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck

GEE Group Posts Q3 Earnings Due to Higher Direct-Hire Revenues

JOB returns to profitability in fiscal Q3 as stronger direct-hire revenues, higher margins and lower costs help offset continued weakness in contract staffing.